A/布里斯班/59/2007 (H1N1)(适应组织培养)(病毒），NR-1_Vaccinia virus

NR-48598?? Purified Influenza A Virus, A/Brisbane/59/2007 (H1N1) (Tissue Culture Adapted)(Viruses)|Influenza A virus|Purified Influenza A Virus, A/Brisbane/59/2007 (H1N1) (Tissue Culture Adapted)|-60°C or colder|BEI ResourcesAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Purified Influenza A Virus, A/Brisbane/59/2007 (H1N1) (Tissue Culture Adapted), NR-48598."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.NR-48598 was purified from BEI Resources NR-31657 (influenza A virus, A/Brisbane/59/2007 (H1N1) (tissue culture adapted)). NR-31657 was derived through tissue culture adaptation of BEI Resources NR-12282 which was isolated in 2007 from a 47-year-old female in Brisbane, Australia. After isolation, this strain was passaged in eggs at the CDC, followed by two egg passages at Baylor College of Medicine prior to deposit. NR-31657 was passaged nine times in Madin-Darby canine kidney (MDCK) cells at BEI Resources.Sequence information is available for influenza A virus, A/Brisbane/59/2007 (H1N1) at the Influenza Research Database. The World Health Organization recommended influenza A/Brisbane/59/2007 (H1N1)-like viruses for use as vaccines during the 2008-2009 and 2009-2010 Northern Hemisphere influenza seasons and during the 2009 Southern Hemisphere influenza season.Each vial contains approximately 1 mL of NR-48598 in Dulbecco's phosphate buffered saline (DPBS).

NR-31657?? Influenza A Virus, A/Brisbane/59/2007 (H1N1) (Tissue Culture Adapted)(Viruses)|Influenza A virus|Influenza A Virus, A/Brisbane/59/2007 (H1N1) (Tissue Culture Adapted)|-60°C or colder|BEI ResourcesAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Influenza A Virus, A/Brisbane/59/2007 (H1N1) (Tissue Culture Adapted), NR-31657."|Quantity limit per order for this item is 5. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.NR-31657 was derived through tissue culture adaptation of BEIR NR-12282 which was isolated in 2007 from a 47-year-old female in Brisbane, Australia. After isolation, this strain was passaged in eggs at the CDC, followed by two egg passages at Baylor College of Medicine prior to deposit.Sequence information is available for influenza A virus, A/Brisbane/59/2007 (H1N1) at the Influenza Research Database. The World Health Organization recommended influenza A/Brisbane/59/2007 (H1N1)-like viruses for use as vaccines during the 2008-2009 and 2009-2010 Northern Hemisphere influenza seasons and during the 2009 Southern Hemisphere influenza season.Each vial contains approximately 1 mL of cell lysate and supernatant from Madin-Darby canine kidney cells (MDCK; ATCC ^? CCL-34?) infected with influenza A virus, A/Brisbane/59/2007 (H1N1) (tissue culture adapted).